94 related articles for article (PubMed ID: 28109403)
1. Total Antioxidant Capacity in beta-thalassemia: A systematic review and meta-analysis of case-control studies.
Manafikhi H; Drummen G; Palmery M; Peluso I
Crit Rev Oncol Hematol; 2017 Feb; 110():35-42. PubMed ID: 28109403
[TBL] [Abstract][Full Text] [Related]
2. Total antioxidant capacity in Mediterranean β-thalassemic patients.
Tsamesidis I; Fozza C; Vagdatli E; Kalpaka A; Cirotto C; Pau MC; Pantaleo A; Turrini F; Grigoriou E; Lymperaki E
Adv Clin Exp Med; 2017 Aug; 26(5):789-793. PubMed ID: 29068574
[TBL] [Abstract][Full Text] [Related]
3. Total antioxidant capacity and ischemia modified albumin in beta thalassemia.
Awadallah S; Al Arrayed K; Bahareth E; Saeed Z
Clin Lab; 2013; 59(5-6):687-91. PubMed ID: 23865371
[TBL] [Abstract][Full Text] [Related]
4. Total Antioxidant Status in Patients with Major β-Thalassemia.
Bazvand F; Shams S; Borji Esfahani M; Koochakzadeh L; Monajemzadeh M; Ashtiani MT; Rezaei N
Iran J Pediatr; 2011 Jun; 21(2):159-65. PubMed ID: 23056782
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant status in beta thalassemia major: a single-center study.
Waseem F; Khemomal KA; Sajid R
Indian J Pathol Microbiol; 2011; 54(4):761-3. PubMed ID: 22234105
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase-1 and oxidative status in common Mediterranean β-thalassaemia mutations trait, and their relations to atherosclerosis.
Labib HA; Etewa RL; Gaber OA; Atfy M; Mostafa TM; Barsoum I
J Clin Pathol; 2011 May; 64(5):437-42. PubMed ID: 21427447
[TBL] [Abstract][Full Text] [Related]
7. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
8. Urinary uric acid and antioxidant capacity in children and adults with Down syndrome.
Campos C; Guzmán R; López-Fernández E; Casado A
Clin Biochem; 2010 Feb; 43(3):228-33. PubMed ID: 19786004
[TBL] [Abstract][Full Text] [Related]
9. The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial.
Darvishi-Khezri H; Salehifar E; Kosaryan M; Karami H; Alipour A; Shaki F; Aliasgharian A
Complement Ther Med; 2017 Dec; 35():25-32. PubMed ID: 29154063
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
[TBL] [Abstract][Full Text] [Related]
11. A Meta-Analysis of Oxidative Stress Markers in Depression.
Liu T; Zhong S; Liao X; Chen J; He T; Lai S; Jia Y
PLoS One; 2015; 10(10):e0138904. PubMed ID: 26445247
[TBL] [Abstract][Full Text] [Related]
12. Oxidation status of β-thalassemia minor and Hb H disease, and its association with glycerol lysis time (GLT50).
Adhiyanto C; Hattori Y; Yamashiro Y; Mella F; Nitta T; Iihoshi M; Araki S; Matar M; Takagi F
Hemoglobin; 2014; 38(3):169-72. PubMed ID: 24611654
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation and antioxidant status in beta-thalassemia.
Meral A; Tuncel P; Sürmen-Gür E; Ozbek R; Oztürk E; Günay U
Pediatr Hematol Oncol; 2000 Dec; 17(8):687-93. PubMed ID: 11127401
[TBL] [Abstract][Full Text] [Related]
14. Plasma total antioxidant capacity is associated with dietary intake and plasma level of antioxidants in postmenopausal women.
Wang Y; Yang M; Lee SG; Davis CG; Kenny A; Koo SI; Chun OK
J Nutr Biochem; 2012 Dec; 23(12):1725-31. PubMed ID: 22617460
[TBL] [Abstract][Full Text] [Related]
15. The Effect of the Mediterranean Diet on Serum Total Antioxidant Capacity in Obese Patients: A Randomized Controlled Trial.
Ortner Hadžiabdić M; Vitali Čepo D; Rahelić D; Božikov V
J Am Coll Nutr; 2016; 35(3):224-35. PubMed ID: 25989426
[TBL] [Abstract][Full Text] [Related]
16. Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State.
Yanpanitch OU; Hatairaktham S; Charoensakdi R; Panichkul N; Fucharoen S; Srichairatanakool S; Siritanaratkul N; Kalpravidh RW
Oxid Med Cell Longev; 2015; 2015():537954. PubMed ID: 26078808
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant capacity in seminal plasma of transfusion-dependent beta-thalassemic patients.
Carpino A; Tarantino P; Rago V; De Sanctis V; Siciliano L
Exp Clin Endocrinol Diabetes; 2004 Mar; 112(3):131-4. PubMed ID: 15052532
[TBL] [Abstract][Full Text] [Related]
18. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis.
Chuang CC; Shiesh SC; Chi CH; Tu YF; Hor LI; Shieh CC; Chen MF
Crit Care; 2006 Feb; 10(1):R36. PubMed ID: 16507162
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in beta-thalassemia.
Matayatsuk C; Poljak A; Bustamante S; Smythe GA; Kalpravidh RW; Sirankapracha P; Fucharoen S; Wilairat P
Redox Rep; 2007; 12(5):219-28. PubMed ID: 17925094
[TBL] [Abstract][Full Text] [Related]
20. Age-related responses in circulating markers of redox status in healthy adolescents and adults during the course of a training macrocycle.
Zalavras A; Fatouros IG; Deli CK; Draganidis D; Theodorou AA; Soulas D; Koutsioras Y; Koutedakis Y; Jamurtas AZ
Oxid Med Cell Longev; 2015; 2015():283921. PubMed ID: 25945150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
